The prevalence of tumors with RET somatic mutations did not differ across BMI categories: 67/114 (58.8%) in under/normal weight, 50/91 (54.9%) in overweight, and 23/49 (53.1%) in patients with obesity (p = 0.37). The gene discussed is RET; the disease is obesity due to melanocortin 4 receptor deficiency.